Canada markets closed

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.3050-0.0050 (-1.61%)
At close: 03:52PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 41.88M
Enterprise Value 35.03M
Trailing P/E N/A
Forward P/E 10.16
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.55
Price/Book (mrq)1.85
Enterprise Value/Revenue 2.11
Enterprise Value/EBITDA -72.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.10
52-Week Change 3-38.00%
S&P500 52-Week Change 316.57%
52 Week High 30.5200
52 Week Low 30.2800
50-Day Moving Average 30.3142
200-Day Moving Average 30.3634

Share Statistics

Avg Vol (3 month) 351.26k
Avg Vol (10 day) 398.63k
Shares Outstanding 5137.3M
Implied Shares Outstanding 6137.3M
Float 8117.12M
% Held by Insiders 113.54%
% Held by Institutions 10.91%
Shares Short (Sept 14, 2023) 424.23k
Short Ratio (Sept 14, 2023) 40.55
Short % of Float (Sept 14, 2023) 4N/A
Short % of Shares Outstanding (Sept 14, 2023) 40.02%
Shares Short (prior month Aug 14, 2023) 417.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 01, 1999
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 29, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin -15.08%
Operating Margin (ttm)-12.08%

Management Effectiveness

Return on Assets (ttm)-3.70%
Return on Equity (ttm)-10.56%

Income Statement

Revenue (ttm)16.58M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)10.40%
Gross Profit (ttm)11.12M
EBITDA -1.32M
Net Income Avi to Common (ttm)-2.5M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.41M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)6.56M
Total Debt/Equity (mrq)28.99%
Current Ratio (mrq)4.39
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)508.07k
Levered Free Cash Flow (ttm)-379.39k